Baotou Tianhe Magnetics Technology
603072
HuangShan Googe
301581
Geovis Insighter Technology
920116
CHICHENG ELECTRIC
834407
Xdc Industries(Shenzhen)Limited
300615
CN Stock MarketDetailed Quotes
600056 China Meheco Group
- 10.67
- -0.11-1.02%
Market Closed Jan 3 15:00 CST
15.96BMarket Cap17.72P/E (TTM)
11.01High10.64Low170.44KlotVolume10.81Open10.78Pre Close184.45MTurnover1.14%Turnover Ratio15.22P/E (Static)1.50BShares13.8852wk High1.37P/B15.96BFloat Cap9.4552wk Low11.86Limit Up1.50BShs Float31.11Historical High9.70Limit Down3.43%Amplitude-1.82Historical Low0.23Dividend TTM10.82Avg Price75.44KlotAsk2.17%Div YieldTTM100Lot Size91.00KlotBid
China Meheco Group News
Announcement on providing guarantees for holding companies
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
Announcement on receipt of the letter of commitment from the controlling shareholder
China Pharmaceutical: Progress Notice on Important Shareholding Companies Planning to Change Actual Controllers
Announcement on the progress of important shareholding companies planning to change the actual controller
Announcement on the progress of the company\'s litigation matters
Announcement on the subsidiary participating in the 10th batch of national collection to be selected
Legal Opinion on the 5th Extraordinary General Meeting of Shareholders of China Pharmaceutical and Health Industry Co., Ltd. in 2024
Announcement of Resolutions of the Fifth Extraordinary General Meeting of Shareholders in 2024
China Pharmaceuticals: Announcement on Subsidiaries Obtaining Drug Registration Approvals
China Pharmaceutical: 2024 Fifth Extraordinary General Meeting of Shareholders Meeting Information
Announcement on the subsidiary obtaining approval for drug registration
2024 Fifth Extraordinary General Meeting of Shareholders Meeting Materials
China Pharmaceutical: Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementary Applications
Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
Announcement on the progress of important shareholding companies planning to change the actual controller
China Pharmaceutical Investor Relations Activity Record Form
Announcement of Resolutions of the 21st Meeting of the 9th Board of Directors
General Technology Liaoning Pharmaceutical Co., Ltd. Shareholders\' Total Equity Value Asset Assessment Report
